189 related articles for article (PubMed ID: 25618371)
1. Recurrent amplification of MYC and TNFRSF11B in 8q24 is associated with poor survival in patients with gastric cancer.
Wang X; Liu Y; Shao D; Qian Z; Dong Z; Sun Y; Xing X; Cheng X; Du H; Hu Y; Li Y; Li L; Dong B; Li Z; Wu A; Wu X; Bu Z; Zong X; Zhu G; Ji Q; Wen XZ; Zhang LH; Ji JF
Gastric Cancer; 2016 Jan; 19(1):116-27. PubMed ID: 25618371
[TBL] [Abstract][Full Text] [Related]
2. Copy Number Gains at 8q24 and 20q11-q13 in Gastric Cancer Are More Common in Intestinal-Type than Diffuse-Type.
Jin DH; Park SE; Lee J; Kim KM; Kim S; Kim DH; Park J
PLoS One; 2015; 10(9):e0137657. PubMed ID: 26360582
[TBL] [Abstract][Full Text] [Related]
3. C-MYC locus amplification as metastasis predictor in intestinal-type gastric adenocarcinomas: CGH study in Brazil.
Burbano RR; Assumpção PP; Leal MF; Calcagno DQ; Guimarães AC; Khayat AS; Takeno SS; Chen ES; De Arruda Cardoso Smith M
Anticancer Res; 2006; 26(4B):2909-14. PubMed ID: 16886612
[TBL] [Abstract][Full Text] [Related]
4. Relative copy number gain of MYC in diagnostic needle biopsies is an independent prognostic factor for prostate cancer patients.
Ribeiro FR; Henrique R; Martins AT; Jerónimo C; Teixeira MR
Eur Urol; 2007 Jul; 52(1):116-25. PubMed ID: 17070983
[TBL] [Abstract][Full Text] [Related]
5. 8q24 amplification is associated with Myc expression and prostate cancer progression and is an independent predictor of recurrence after radical prostatectomy.
Fromont G; Godet J; Peyret A; Irani J; Celhay O; Rozet F; Cathelineau X; Cussenot O
Hum Pathol; 2013 Aug; 44(8):1617-23. PubMed ID: 23574779
[TBL] [Abstract][Full Text] [Related]
6. 8q24 Copy number gains and expression of the c-myc mRNA stabilizing protein CRD-BP in primary breast carcinomas.
Ioannidis P; Mahaira L; Papadopoulou A; Teixeira MR; Heim S; Andersen JA; Evangelou E; Dafni U; Pandis N; Trangas T
Int J Cancer; 2003 Mar; 104(1):54-9. PubMed ID: 12532419
[TBL] [Abstract][Full Text] [Related]
7. Relationship of Amplification and Expression of the C-MYC Gene with Survival among Gastric Cancer Patients.
Khaleghian M; Shakoori A; Razavi AE; Azimi C
Asian Pac J Cancer Prev; 2015; 16(16):7061-9. PubMed ID: 26514491
[TBL] [Abstract][Full Text] [Related]
8. Detection of genetic alterations in gastric cancer patients from Saudi Arabia using comparative genomic hybridization (CGH).
Bibi F; Ali I; Naseer MI; Ali Mohamoud HS; Yasir M; Alvi SA; Jiman-Fatani AA; Sawan A; Azhar EI
PLoS One; 2018; 13(9):e0202576. PubMed ID: 30212456
[TBL] [Abstract][Full Text] [Related]
9. Outcome prediction in pediatric medulloblastoma based on DNA copy-number aberrations of chromosomes 6q and 17q and the MYC and MYCN loci.
Pfister S; Remke M; Benner A; Mendrzyk F; Toedt G; Felsberg J; Wittmann A; Devens F; Gerber NU; Joos S; Kulozik A; Reifenberger G; Rutkowski S; Wiestler OD; Radlwimmer B; Scheurlen W; Lichter P; Korshunov A
J Clin Oncol; 2009 Apr; 27(10):1627-36. PubMed ID: 19255330
[TBL] [Abstract][Full Text] [Related]
10. The rs6983267 SNP is associated with MYC transcription efficiency, which promotes progression and worsens prognosis of colorectal cancer.
Takatsuno Y; Mimori K; Yamamoto K; Sato T; Niida A; Inoue H; Imoto S; Kawano S; Yamaguchi R; Toh H; Iinuma H; Ishimaru S; Ishii H; Suzuki S; Tokudome S; Watanabe M; Tanaka J; Kudo SE; Mochizuki H; Kusunoki M; Yamada K; Shimada Y; Moriya Y; Miyano S; Sugihara K; Mori M
Ann Surg Oncol; 2013 Apr; 20(4):1395-402. PubMed ID: 22976378
[TBL] [Abstract][Full Text] [Related]
11. Genome-wide analysis of DNA copy number alterations and gene expression in gastric cancer.
Tsukamoto Y; Uchida T; Karnan S; Noguchi T; Nguyen LT; Tanigawa M; Takeuchi I; Matsuura K; Hijiya N; Nakada C; Kishida T; Kawahara K; Ito H; Murakami K; Fujioka T; Seto M; Moriyama M
J Pathol; 2008 Dec; 216(4):471-82. PubMed ID: 18798223
[TBL] [Abstract][Full Text] [Related]
12. MYC amplification and polysomy 8 in chondrosarcoma: array comparative genomic hybridization, fluorescent in situ hybridization, and association with outcome.
Morrison C; Radmacher M; Mohammed N; Suster D; Auer H; Jones S; Riggenbach J; Kelbick N; Bos G; Mayerson J
J Clin Oncol; 2005 Dec; 23(36):9369-76. PubMed ID: 16361637
[TBL] [Abstract][Full Text] [Related]
13. Gains and amplifications of c-myc, EGFR, and 20.q13 loci in the no dysplasia-dysplasia-adenocarcinoma sequence of Barrett's esophagus.
Rygiel AM; Milano F; Ten Kate FJ; Schaap A; Wang KK; Peppelenbosch MP; Bergman JJ; Krishnadath KK
Cancer Epidemiol Biomarkers Prev; 2008 Jun; 17(6):1380-5. PubMed ID: 18559552
[TBL] [Abstract][Full Text] [Related]
14. Clinical significance of alterations of chromosome 8 in high-grade, advanced, nonmetastatic prostate carcinoma.
Sato K; Qian J; Slezak JM; Lieber MM; Bostwick DG; Bergstralh EJ; Jenkins RB
J Natl Cancer Inst; 1999 Sep; 91(18):1574-80. PubMed ID: 10491435
[TBL] [Abstract][Full Text] [Related]
15. Correlation between genomic alterations assessed by array comparative genomic hybridization, prognostically informative histologic subtype, stage, and patient survival in gastric cancer.
Rossi E; Klersy C; Manca R; Zuffardi O; Solcia E
Hum Pathol; 2011 Dec; 42(12):1937-45. PubMed ID: 21676433
[TBL] [Abstract][Full Text] [Related]
16. TNK2 gene amplification is a novel predictor of a poor prognosis in patients with gastric cancer.
Shinmura K; Kiyose S; Nagura K; Igarashi H; Inoue Y; Nakamura S; Maeda M; Baba M; Konno H; Sugimura H
J Surg Oncol; 2014 Mar; 109(3):189-97. PubMed ID: 24178904
[TBL] [Abstract][Full Text] [Related]
17. Low level c-myc gene amplification in gastric cancer detected by dual color fluorescence in situ hybridization analysis.
Suzuki S; Tenjin T; Watanabe H; Matsushima S; Shibuya T; Tanaka S
J Surg Oncol; 1997 Nov; 66(3):173-8. PubMed ID: 9369962
[TBL] [Abstract][Full Text] [Related]
18. Novel regions of amplification on 8q distinct from the MYC locus and frequently altered in oral dysplasia and cancer.
Garnis C; Coe BP; Ishkanian A; Zhang L; Rosin MP; Lam WL
Genes Chromosomes Cancer; 2004 Jan; 39(1):93-8. PubMed ID: 14603447
[TBL] [Abstract][Full Text] [Related]
19. Relations of the c-myc gene and chromosome 8 in non-small cell lung cancer: analysis by fluorescence in situ hybridization.
Kubokura H; Tenjin T; Akiyama H; Koizumi K; Nishimura H; Yamamoto M; Tanaka S
Ann Thorac Cardiovasc Surg; 2001 Aug; 7(4):197-203. PubMed ID: 11578259
[TBL] [Abstract][Full Text] [Related]
20. Amplification of 8q21 in breast cancer is independent of MYC and associated with poor patient outcome.
Choschzick M; Lassen P; Lebeau A; Marx AH; Terracciano L; Heilenkötter U; Jaenicke F; Bokemeyer C; Izbicki J; Sauter G; Simon R
Mod Pathol; 2010 Apr; 23(4):603-10. PubMed ID: 20139910
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
